|Bid||157.34 x 300|
|Ask||167.69 x 100|
|Day's Range||157.95 - 158.94|
|52 Week Range||126.42 - 160.20|
|PE Ratio (TTM)||9.21|
|Expense Ratio (net)||0.25%|
Small-capitalization stock investors were defensive going into the 2017, but they have quickly changed their tune, turning to more growth-weighted smaller company picks. Investors can also gain diversified ...
Eli Lilly’s (LLY) Captisol-enabled drug Prexasertib is currently being evaluated in multiple oncology indications such as head and neck cancer, small-cell lung cancer (or SCLC), and advanced metastatic ...
Ligand Pharmaceuticals (LGND) expects its licensees to invest ~$2.0 billion for advancing more than 155 partnered research and development programs in 2017.